Date: 6/19/2007Length: 00:6:49
Size: 3.12MB
Thought Leader: Mollie Shields-Uehling, President and CEO, SAFE Biopharma Association
Dan Limbach, Producer, PharmaVOICE Webcast Network, speaks with Mollie Shields-Uehling, who provides an overview of the SAFE digital signature technology, the benefits of electronic submissions, and which companies are adopting this model.
Play Full Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
1 comment:
I have read a lot about digital signatures and how they are benefiting to an organization by lowering the overall cost that is spend in managing the information. but I would like to know more about this scheme. I watched the podcast that you have shared above and find it very useful.
e signatures
Post a Comment